The Centers for Disease Control and Prevention, NCIRD/ISD, 1600 Clifton Rd. NE, Mailstop A19, Atlanta, GA, 30333, hereby announces its intent to issue a sole source contract to Pfizer, Inc. 265 East 42nd Street New York, NY 10017-5703 to add 75,000 doses of Trumenba (MenB) vaccine to the existing contract.

Posting Date: 03/06/2015

Closing Response Date: 5:00 pm EST on 03/21/2015

NAICS Code: 325412

Period of Performance: 04/01/2015 to 06/30/2015

Solicitation Number: 2014-N-15815 (Original Award Solicitation)

Contract Award Amount: $13,462,500.00

Contract Line Item Number: 0001 & 0002

Contract Award Date: 07/01/2014

Contract Place of Performance: 1600 Clifton Road NE Atlanta, GA 30333

The statutory authority permitting other than full and open competition is 41 U.S.C. 253(c)(1) as cited in FAR 13.106-1(b)(1)(i). This acquisition is to purchase Bexsero® (rMenB+OMV NZ) vaccine for adults so that the vaccine can be used to vaccinate high risk individuals as recommended by CDC's Advisory Committee on Immunization Practices (ACIP). Meningococcal disease is a life-threatening illness caused by bacteria that can infect the bloodstream (sepsis) and the lining that surrounds the brain and spinal cord (meningitis). Neisseria meningitidis is a leading cause of bacterial meningitis. The bacteria are transmitted from person to person through respiratory or throat secretions (e.g., by coughing, kissing or sharing eating utensils). Based on CDC data for 2012, about 500 total cases of meningococcal disease were reported in the U.S., of which 160 were caused by serogroup B. Meningococcal disease can be treated with antibiotics to reduce the risk of death or serious long-term problems, but even with immediate medical attention these outcomes are not always prevented. Vaccination is the most effective way to prevent meningococcal disease.

Responsible sources that believe they possess the expertise and capabilities identified above are encouraged to submit to the Contracting Officer within 15 days from the posting date of this notice, their written capabilities statement, proposal or quotation which shall be considered by the agency for future procurement. Please forward the capability statement and/or pricing information to Michael Harwell, Contracting Specialist, Reference 200-2014-58788 00007, Centers for Disease Control, Procurement and Grants Office, ATTN: Michael Harwell, MS: K14, 2920 Brandywine Road, Atlanta, GA 30341. All vendors must be registered in the System for Award Management (SAM) prior to an award of a federal contract. The website is: www.sam.gov.

This is a posting of a sole source award to Pfizer, Inc. and is not a request for competition.

PGO POC: Michael Harwell [email protected] 770-488-3224